Hemosure®

Hemosure® Inc. has been leading the field of clinical diagnostic test kits and medical devices since 2003. The company prides itself on the enduring success of its Fecal Occult Blood test (iFOB), maintaining its position as the #1 test in the US for nearly a decade, showcasing its quality and effectiveness. The recent introduction of the FDA cleared, Hemosure® Accu-Reader A 100 product line, an automated immunochemical Fecal Occult Blood diagnostic system, marks another significant milestone. This demonstrates the company's commitment to safety and accuracy through rigorous testing and evaluation. The automation provided by the Hemosure® Accu-Reader A 100 has the potential to enhance the standard of care in diagnosing gastrointestinal disorders by detecting occult blood in stool samples in just 5 minutes, boosting efficiency and reliability for healthcare professionals. Situated in Irwindale, California, the company's proximity to downtown Los Angeles enhances accessibility and collaboration with medical professionals and institutions in the area. Hemosure® Inc. is at the forefront of medical diagnostics, striving to contribute to the improvement of the quality of life for all.